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Macroautophagy (hereafter autophagy) is a multistep intracellular catabolic process with
pleiotropic implications in cell fate. Attending to its activation, autophagy can be classified
into inducible or constitutive. Constitutive, or basal autophagy, unfolds under nutrient-
replete conditions to maintain the cellular homeostasis. Autophagy inhibitory drugs are
powerful tools to interrogate the role of autophagy and its consequences on cell fate.
However, 3-methyladenine and various of these compounds present an intrinsic capacity
to trigger cell death, for instance the broadly-employed 3-methyladenine. To elucidate
whether the inhibition of basal autophagy is causative of cell demise, we have employed
several representative compounds acting at different phases of the autophagic process:
initiation (SBI0206965 and MHY1485), nucleation (3-methyladenine, SAR405, Spautin-1
and Cpd18), and completion (Bafilomycin A1 and Chloroquine). These compounds
inhibited the basal autophagy of MEF cultures in growing conditions. Among them, 3-
methyladenine, SBI-0206965, Chloroquine, and Bafilomycin A1 triggered BAX- and/or
BAK-dependent cytotoxicity and caspase activation. 3-methyladenine was the only
compound to induce a consistent and abrupt decrease in cell viability across a series
of ontologically unrelated human cell lines. 3-methyladenine-induced cytotoxicity was not
driven by the inhibition of the AKT/mTOR axis. Autophagy-deficient Fip200−/− MEFs
displayed an increased sensitivity to activate caspases and to undergo cell death in
response to 3-methyladenine. The cytotoxicity induced by 3-methyladenine correlated
with a massive DNA damage, as shown by g-H2A.X. This genotoxicity was observed at 10
mM 3-methyladenine, the usual concentration to inhibit autophagy and was maximized inin.org October 2020 | Volume 11 | Article 5803431
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Frontiers in Pharmacology | www.frontiersFip200−/−MEFs. In sum, our results suggest that, in growing conditions, autophagy acts
as a protective mechanism to diminish the intrinsic cytotoxicity of 3-methyladenine.
However, when the cellular stress exerted by 3-methyladenine surpasses the protective
effect of basal autophagy, caspase activation and DNA damage compromise the
cell viability.Keywords: 3-methyladenine, autophagy inhibitor, basal autophagy, Ɣ-H2A.X, apoptosisINTRODUCTION
Macroautophagy (herein, autophagy) is a highly regulated
cellular process by which cellular constituents are engulfed into
autophagosomes before being degraded and reused. Autophagy
is a constitutive process observed in most tissues in non-stressed
nutrient-replete conditions (basal autophagy). However, it also
increases in response to environmental cues such as nutrient
starvation or the exposure to a plethora of stressors (inducible
autophagy) (Kuma et al., 2004; Degterev et al., 2005; Mizushima,
2007; Mattiolo et al., 2015). Basal autophagy participates in
essential housekeeping functions like the elimination of
damaged organel les , toxic aggregates of misfolded
macromolecules and, probably, in other crucial aspects of the
cell and organism homeostasis (Boya et al., 2013). Nonetheless,
over-stimulated autophagy may also lead to cell death type II
(Clarke, 1990) due to an excessive degradation of intracellular
components (Bialik et al., 2018). Regardless of the final cellular
outcome, inappropriate levels of autophagy are at the origin of
many pathologies, and thus modulation of this process is
believed to have great therapeutic avenues. In this sense,
inhibition of autophagy could be beneficial in the treatment of
some types of cancer, chronic obstructive pulmonary diseases,
neonatal asphyxia, and specific inflammatory-based illnesses
(Galluzzi et al., 2017). Chloroquine and its derivative,
hydroxychloroquine, are the only FDA-licensed drugs
approved in clinical trials that aim to block autophagy. This
historical shortage has been compensated by the development of
an expanding arsenal of new pharmacological inhibitors. The
selection of those with a better inhibitory profile and with less
unspecific cytotoxicity demands of an accurate characterization.
Prior to the commitment into autophagy, cells must integrate
information from hormonal, metabolic and stress stimuli to
ensure that cell growth and proliferation are only engaged in3meA, 3-methyladenine adducts; AB,
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in.org 2favorable conditions. This coordination is achieved by cellular
sensors like mTORC1 (mammalian target of rapamycin complex
1), which in its active form promotes cell growth and directs the
metabolism into anabolic reactions. While the inhibition of
mTORC1 triggers the activation of autophagy, maintaining a
proper function stalls the process. Indeed, this strategy has been
pharmacologically exploited by the autophagy inhibitory
compound MHY1485, an activator of mTOR by a yet
unknown mechanism (Choi et al., 2012). The autophagic
process is orchestrated by the sequential activation of a series
of protein complexes. Based on their order of participation,
several autophagic phases are proposed. The “initiation phase”
(Figure 1) involves the activation of the “ULK Initiation
Complex”, which is under control of cellular sensors such as
mTORC1 (D. Egan et al., 2011). This complex contains key
serine/threonine kinases such as Unc-51-like kinase 1 (ULK1) or
ULK2 and the scaffold protein FIP200, among other
components. SBI-0206965 is an autophagy inhibitor that
suppresses the kinase activity of ULK1/2 (D. F. Egan et al.,
2015). The “initiation phase” gives way to the “Nucleation phase”
of autophagy, which also comprises the elongation of the
phagophore (Figure 1). This phase begins with the activation
of the “VPS34 Nucleation Complex” at the sites of
autophagosome formation. VPS34 (vacuolar protein sorting
34) is a class 3 phosphatidylinositol 3-kinase (PI3KC3) that
forms a multiprotein complex with BECLIN-1. The generation
of PI3P (phosphatidyl inositol 3-phosphate) by VPS34 and the
recruitment of PI3P-binding proteins is a crucial step for the
nucleation and elongation of the growing autophagosomes,
which eventually seal to originate a mature vesicle (Jaber et al.,
2012). 3-methyladenine has become a standard tool to test the
involvement of autophagy in numerous biological paradigms
through its blockage of VPS34 (Seglen and Gordon, 1982).
Nonetheless, the high concentrations of 3-methyladenine
required to block autophagy are facilitating its off-target effects
(Wu et al., 2013). In addition, 3-methyladenine is not specific for
VPS34, being class I PI3K (PI3KC1) also inhibited (Wu et al.,
2010). To overcome these limitations, Cpd18 and SAR405, two
inhibitors of VPS34 kinase activity with improved potency and
selectivity, have been developed (Wu et al., 2013; Ronan et al.,
2014; Pasquier, 2015). On the other hand, Spautin-1 inactivates
VPS34 complex through the inhibition of two ubiquitin-specific
peptidases (USPs) and thus increasing BECLIN-1 ubiquitination
and degradation (Liu et al., 2011).
The loading of the autophagic cargo occurs during nucleation
and elongation phases. It requires the participation of specific
ubiquitin-like conjugation enzymes such as the E3-like complexOctober 2020 | Volume 11 | Article 580343
Chicote et al. 3-Methyladenine-Driven Cell Death and Genotoxicityformed by ATG16L1-ATG5-ATG12, which catalyzes the
conjugation of cleaved MAP1LC3/LC3 to the lipid
phosphatidylethanolamine, originating the LC3-II. LC3-II and
the cargo receptor p62/SQSTM1 play relevant roles in cargo
recognition and loading (Schaaf et al., 2016).
During the “Fusion phase”, the mature autophagosomes fuse
to lysosomes originating the autolysosomes. These organelles
contain the proteases in charge of the “Degradation” phase,
whereby the cargo and structural molecules such as LC3-II and
p62/SQSTM1 will be proteolyzed and recycled. For simplicity
reasons, we clustered these final phases under the term
“Completion phase of the autophagic process” (Figure 1).
Chloroquine is a classical anti-malarial drug that suppresses
autophagy by inhibiting the fusion of autophagosomes and
lysosomes (Mauthe et al., 2018). On the other hand,
Bafilomycin A1 belongs to the macrolide-type of antibioticsFrontiers in Pharmacology | www.frontiersin.org 3and inhibits the vacuolar H+-V-ATPase (V-ATPase), which is
in charge of the lysosomal acidification. The pharmacological
inhibition of lysosomal function allows the determination of the
autophagic flux by comparing the accumulation of LC3-II and
p62 in inhibited and non-inhibited conditions (Mizushima et al.,
2010; Klionsky et al., 2016).
In this study, we set out to identify the autophagy inhibitory
compounds that were cytotoxic in growing conditions, regardless
of their autophagy inhibitory function. All the compounds tested
were able to block basal autophagy but only SBI-0206965
(“Initiation phase”), 3-methyladenine (“Nucleation phase”),
and Bafilomycin A1 and Chloroquine (“Completion phase”)
triggered regulated cell death with the implication of caspases,
and BAX and/or BAK. Among these drugs, 3-methyladenine
showed the strongest activity at diminishing cell viability across
four ontologically-unrelated human cell lines. The impairment ofFIGURE 1 | Schematic illustration depicting the process of autophagy and the targets of the autophagy inhibitory drugs. mTOR is a serine/threonine protein kinase
that regulates cell growth and anabolism. Associated to other proteins, mTOR forms a complex known as mTORC1, a sensor of the nutritional state of the cell. In
growing conditions, mTORC1 constitutively blocks the “ULK initiation complex” and hence, autophagy. MHY1485 is an activator of mTOR that acts through a yet
unknown mechanism. The “ULK initiation complex” contains ULK1 or its homolog ULK2, FIP200, and ATG13 and triggers the first step of autophagy known as
Initiation. SBI-0206965 is an inhibitor of ULK1 and ULK2. The “ULK initiation complex” drives the formation of the precursors of the autophagosomes through the
direct activation of the “VPS34 Nucleation Complex”, for instance by phosphorylating VPS34 (Vacuolar Protein Sorting 34) and BECLIN-1. Spautin-1 triggers the
destruction of BECLIN-1 through the inhibition of two of its deubiquitinases. On the other hand, VPS34 is a class 3 phosphatidylinositol 3-phosphate-kinase (PI3KC3)
accountable for the production of the phospholipid phosphatidylinositol 3-phosphate (PI3P) necessary for the recruitment of PI3P-binding proteins that lead the
nucleation and elongation of the vesicles. 3-MA, its close analog Cpd18 and SAR405 are inhibitors of VPS34. In addition, a third complex consisting of ATG16L1–
ATG5–ATG12 plays a key role in the “Nucleation and Elongation” phase. This complex orchestrates a conjugation similar to what E3-ubiquitin ligases do, but in this
case, they catalyze the transfer of the “ubiquitin-like” LC3-I to the lipid phosphatidylethanolamine, giving rise to LC3-II. p62/SQSTM1 is an autophagy receptor that
binds the ubiquitinylated cargo and directs it to the growing double-membrane autophagosome by interacting with LC3-II and other related proteins. Finally, the
“Completion of the autophagic process” includes two phases: “Fusion” and “Degradation”. During “Fusion”, the mature autophagosome fuses with lysosomes,
originating a new vesicle known as autolysosome. The activation of the H+ pumps triggers the activation of the lysosomal hydrolases, which are in charge of
degrading the cargo. Bafilomycin A1 inhibits the acidification of the autolysosome by blocking the vacuolar-type H
+-V-ATPase while Chloroquine impairs the fusion of
lysosomes with autophagosomes. Finally, products from degradation reach the cytosol through permeases and enter into metabolic circuitries. All drugs are
depicted within squares.October 2020 | Volume 11 | Article 580343
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methyladenine-driven cytotoxicity. 3-methyladenine-mediated
cell death occurred independently of its basal autophagy
blocking action, as demonstrated by using Fip200−/− MEFs.
However, basal autophagy acted as a protective mechanism
facing 3-methyladenine-induced caspase activation and cell
death. Finally, cells cultured in the presence of cytotoxic
concentrations of 3-methyladenine, displayed g-H2A.X. Our
study demonstrates that 3-methyladenine works as a genotoxic
compound independently of its ability to block basal autophagy.MATERIALS AND METHODS
Cell Lines and Cell Culture Conditions
Immortalized Bax−/− Bak−/− (DKO) MEFs and their wild type
(MEFs) counterparts were obtained from Dr. Korsmeyer’s
laboratory. Fip200−/− MEFs and their counterparts (Fip200+/+
MEFs) were gently supplied by Dr. Molinari and originated at
Dr. Guan’s laboratory. SH-SY5Y, HeLa, HEK 293 cell lines were
obtained from the American Type Culture Collection (ATCC;
Manassas, VA, USA). HCT116 human adenocarcinoma cell line
was kindly provided by Dr Vogelstein (The Howard Hughes
Medical Institute, Sidney Kimmel Comprehensive Cancer
Center, The Johns Hopkins School of Medicine, Baltimore,
MD, USA).
All cell lines were maintained in DMEM (Gibco, Paisley,
Scotland, UK) supplemented with 10% FCS (Gibco, Paisley,
Scotland, UK) with the exception of HCT116, which were
maintained in McCoy’s 5A (Biowest, Riverside, MO, USA)
supplemented with 10% FCS. 5 mg/ml Plasmocin™
(InvivoGen, San Diego, CA, USA) was used as the media
antibiotic. General culturing conditions were 37°C and a
water-saturated, 5% CO2 atmosphere. Culture dishes and other
plastic disposable tools were supplied by VWR (Radnor, PA,
USA) and Becton Dickinson (Franklin Lakes, NJ, USA).
Drug Treatment of Cells in Culture
As autophagy inhibitory drugs, we have used MHY1485 (Ref.
500554), Spautin-1 (Ref. 567569) and Cpd18 (Ref. 505980) from
Calbiochem, part of Merck, Darmstadt, Germany. SBI-0206965
(Ref. S-7885) and SAR405 (Ref. S7682) were purchased from
Selleck chemicals, Houston, TX, USA. MHY1485, SBI-0206965,
SAR405 and Spautin-1 were dissolved in DMSO at a final
concentration of 20 mM, 20 mM, 10 mM and 10 mM
respectively. A 8 mM working solution of Cpd18 was prepared
in HBSS without glucose. 3-methyladenine was obtained either
from Acros Organics (Morris Planes, NJ, USA) or ApexBio
(A8353, Huston, TX, USA) and dissolved in HBSS (Hank’s
buffer salt solution) without glucose at a final concentration of
40 mM. Before treating the cells, 3-MA was sonicated during
20 min to prevent the formation of aggregates. Chloroquine
(Sigma-Aldrich, C6628) was dissolved in PBS at a final
concentration of 50 mM. Wortmannin (SC-3505) was
purchased from Santa Cruz Biotechnology Inc., Dallas, Texas,
USA and prepared in PBS at a final concentration of 100 mM.Frontiers in Pharmacology | www.frontiersin.org 4Bafilomycin A1 (Ref. 11038, Cayman chemical, Ann Arbor, MI,
USA) was dissolved in DMSO at a final concentration of 1 mM.
To treat cells, a 100 mM working solution was prepared in PBS.
From these stock solutions, the drugs were delivered to the
culture media and adjusted to the final concentrations reported
in the text and figures. All the treatments were performed in the
presence of ¼ HBSS + ¾ DMEM 10% FBS, the maximal
concentrations of HBSS without glucose reached with the 10
mM 3-MA. Cells were also treated with this medium plus the
highest concentration of DMSO resulting from the drug
treatments, thus becoming the drug-untreated control of our
experiments. DMSO concentrations never surpassed a 0.1% in
the medium. At this concentration, we have observed no
alteration in the cultured cells. To inhibit apoptotic caspases,
cell cultures were treated with the pan-caspase inhibitor q-VD-
OPh (Ref 551476, Calbiochem, part of Merck, Darmstadt,
Germany) dissolved in DMSO and employed at the
concentration indicated in the figure legend.
Cell Staining Procedures
In order to visualize acidic vesicular organelles (AVOs), cells were
stained with the monodansylcadaverine reagent (sc-214851, Santa
Cruz Biotechnology Inc., Dallas, Texas, USA). In brief, cell cultures
were incubated for 15 min with 50 mM monodansylcadaverine in
the treatment medium before replacing it with fresh medium. To
evidence the autophagic flux, DalGreen (D675, Dojindo, Japan)
staining was used according to the supplier’s instructions. Briefly,
2,500MEF cells were plated in 96-well plates. After 24 h, DALGreen
reagent diluted in freshmediumwas added to the cultures to reach a
final concentration of 1 µM. After an incubation of 30 min, loading
medium was replaced with fresh cell culture medium. Next, cells
were subjected to the treatment conditions indicated in the figure. In
order to detect the apoptotic nuclear morphology, cultured cells
were directly stained with bis-benzimide (Hoechst 33342) at a final
concentration of 2 ug/ml. Following the aforementioned
procedures, cells were observed with an inverted fluorescence
microscope (Nikon Eclipse Ts2R) and images captured and
processed through NIS-Elements Basic Research Software. To
quantify the number of monodansylcadaverine positive vesicles or
the DALGreen Fluorescent intensity per cell, images of at least 50
cells from three independent wells were analyzed using ImageJ
software (National Institutes of Health, Bethesda, MD, USA).
Cell Viability Determinations
To determine cell survival, alamarBlue™ Cell Viability Assay
Reagent (Pierce Biotechnology, Rockford, IL, USA) was used
according to the manufacturer’s protocol. This assay couples a
non-specific cellular reductase activity of viable cells to the
reduction of alamarBlue (AB) into a fluorescent product.
Briefly, cells plated in 96-well plates were subjected to drug
treatments, then AB (1/10th of the final volume) was added to
each well. After an incubation of 3 h, fluorescent signal was
quantified by means of a fluorescence plate reader (Infinite
M200, Tecan). Percentage of viability was obtained by referring
these values to the ones obtained in untreated control. To
determine cell death, cells were collected by trypsinization and
stained with 5 mg/ml propidium iodide (PI) from Sigma-AldrichOctober 2020 | Volume 11 | Article 580343
Chicote et al. 3-Methyladenine-Driven Cell Death and Genotoxicity(St. Louis, MO, USA) directly in the cell culture medium.
Following 15 min incubation at room temperature, cells were
subjected to flow cytometry analysis.
Measurement of Caspase Activation
The activity of effector caspases (DEVDase activity) was obtained by
quantifying the fluorescence released from Ac-DEVD-afc substrate
(Cayman chemical, Ann Arbor, MI, USA). Cells in culture were
lysed and incubated in the presence of this substrate at 37°C. This
procedure was initially validated by Ribas et al. (Ribas et al., 2005)
and routinely used in our laboratory afterwards.
Western-Blot
To obtain cytosolic extracts, cells were harvested and lysed in a
buffer containing 50 mM NaCl, 25 mM Tris pH 6.8, 1 mM
EDTA, 0.1% Triton X-100 supplemented with the Protease
Inhibitor Cocktail Set III, EDTA-free (Calbiochem, part of
Merck, Darmstadt, Germany). If a protein phosphorylation
was examined, the phosphatase Inhibitor Cocktail II (Alfa
Aesar part of Thermo Fisher scientific Inc., Kandel, Germany)
was added to the buffer. Cell lysates were centrifuged at 15,000
r.p.m. for 30 min at 4°C before the determination of the protein
content. To study histone H2A.X, whole cell protein extracts
were obtained by lysing cells in a buffer containing 100 mM Tris/
ClH pH 6.8, 1% SDS, 1 mM EDTA plus the protease and
phosphatase inhibitory cocktails afore mentioned. Cell lysates
were sonicated on ice for two rounds of 10 s before being clarified
by centrifugation at 15,000 r.p.m. for 30 min. The amount of
protein in the supernatants was quantified by a modified Lowry
assay (DC protein assay, Bio-Rad, Hercules, CA, USA). Equal
amounts of protein were loaded in the wells of SDS-
polyacrylamide gels and separated in an electric field. Next,
gels were electrotransferred onto 0.45 mm PVDF membranes
(EMD Millipore, part of Merck Darmstadt, Germany) and
blocked with Tris-buffered saline with 0.1% Tween 20 and 5%
non-fat dry milk. Blocked membranes were probed with the
following specific primary antibodies: anti-LC3B (1:1,000;
L7543) from Sigma-Aldrich (St. Louis, MO, USA), anti-p62
(1:2,000; PM045) from Medical and Biological laboratories Co.
“MBL” (Nagoya, Japan), anti-caspase 3 (1:2,000; clone 8G10,
#9665 or 1:1,000; #9662), anti-phospho Ser757-ULK1 (1:1,000;
#6888), anti-ULK1 (1:1,000; clone D8H5, #8054), anti-phospho
Thr37/46-4E-BP1(1:1,000; clone 136B4, #2855), anti-4E-BP1
(1:1,000; clone 53H11, #9644) from Cell Signaling Technology,
anti-a-Fodrin (1:15,000; MAB1622) and anti- H2A.X (1:1,000;
#07-627) anti-phospho Ser139–H2A.X (1:1,000; clone JBW301,
#05-636-I) from Millipore (part of Merck, Darmstadt,
Germany). After incubation with the corresponding
horseradish peroxidase-conjugated secondary antibody, the
immunoblots were developed with the Immobilon™ reagent
(Mi l l ipore , par t o f Merck , Darmstadt , Germany) .
Chemiluminescent images were recorded by means of a
Chemidoc XRS apparatus and analyzed with the Image Lab
version 4.0.1 software from Bio-Rad (Bio-Rad, Marnes-la-
Coquette, France). Loading of each sample was assessed by
staining the membranes during 5 min in a solution containingFrontiers in Pharmacology | www.frontiersin.org 510% methanol, 2% acetic acid, and 0.1% of Naphthol blue black
Sigma-Aldrich (St. Louis, MO, USA). Then, membranes were de-
stained in a 10% methanol and 2% acetic acid solution during
10 min. Membranes were allowed to dry before capturing images
with the Chemidoc XRS apparatus. Otherwise stated, the
westerns presented are a representative of at least three
independent experiments.
To calculate the percentage of Basal Autophagic Flux (LC3-II
T+BafA1/LC3-II T), LC3-II bands were detected on Chemidoc XRS
(Bio-Rad, Marnes-la-Coquette, France). LC3-II protein levels
were determined by computer-assisted densitometric analysis
(Image Lab version 4.0.1 software from Bio-Rad). The density of
each band was normalized to its respective loading control
(Naphtol blue stained lane). Data obtained were expressed as
the intensity ratio of LC3-II in cells subjected to an experimental
condition in the presence of Bafilomycin A1 (“T+ BafA1”) to that
of the same protein in cells subjected to the same experimental
condition in the absence of Bafilomycin A1 (“T”). These intensity
ratios were referred to the ratios of the basal autophagic flux in
untreated cultures and expressed as a percentage, being 100%
value assigned to control untreated cultures.
The intensity of the protein bands was quantified with the
assistance of densitometric software (Image Lab version 4.0.1
software from Bio-Rad). After a step of normalization (see Figure
legend), ratios were displayed in the figures.RESULTS
Cytotoxicity Induced by Autophagy
Inhibitory Compounds Is Observed at
Concentrations Inhibiting the Basal
Autophagic Process
Pharmacological inhibitors of autophagy are a common tool to
interrogate the role of autophagy in a specific setting. As detailed
in Figure 1, autophagy inhibitors acting at the initiation phase
(MHY1485 -MHY- and SBI0206965 -SBI-), at the nucleation
phase (3-methyladenine -3-MA-, Cpd18, Spautin-1 -SPT-1- and
SAR405 -SAR-) or at the completion phase (Chloroquine -CQ-
and BafilomycinA1 -BafA1-) were selected to be studied. To
quickly screen the inhibitory effects of these chemicals on basal
autophagy, first we employed a method to evidence the presence
of acidic vesicular organelles (AVOs). MEFs subjected for 6 h to
previously reported concentrations of the selected autophagy
inhibitors (Choi et al., 2012; Zhao et al., 2016; Wu et al., 2010; Liu
et al., 2011; Wu et al., 2013; Manic et al., 2014; Shao et al., 2014;
Egan et al., 2015; Martin et al., 2018) were stained with the
lysosomotropic fluorophore monodansylcadaverine (MDC). As
observed in Figure 2A, a consistent reduction of AVOs was
observed in response to the inhibitors. These results were
corroborated through the quantification of MDC-positive
vesicles per cell (Supplementary Figure 1). The accumulation
of AVOs in response to CQ was a previously reported
phenomenon and was employed as a positive control to
evidence the maximal amount of MDC-stained vesiclesOctober 2020 | Volume 11 | Article 580343
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accumulation of MDC into AVOs, was employed as a negative
control (Bowman et al., 1988). Next, we explored the time-
dependent changes of LC3-II, a widely used read-out of the
autophagic flux. Treatments consisted in incubations for 3 h or
12 h with the different inhibitors in the presence or absence ofFrontiers in Pharmacology | www.frontiersin.org 6BafA1 for the last 3 h of treatment. Again, we confirmed that all
the inhibitors blocked the basal autophagic flux to some extent
(Figure 2B). Remarkably, at 3 h, MHY, SAR, and CQ reduced
the autophagic flux percentage to less than 25% while Cpd18
reduced it to a 63% compared with the untreated control (Figure
2B). At 12 h, all the compounds diminished the percentage ofA
B
FIGURE 2 | Basal autophagy is blocked in response to autophagy inhibitory drugs. (A) MEFs treated for 6 h with the drugs at the concentrations stated in the panel
were stained with monodansylcadaverine (MDC) and observed with a fluorescence microscope. Acidic vesicles are displayed as puncta. Bar = 20 mm.
Representative images of at least two independent experiments are shown. (B) Protein extracts of MEFs treated for 3 and 12 h, as indicated in the panel, were
analyzed by western blot. “12 h BafA1” is a control and refers to MEFs treated for 12 h with this drug. Intensity of the LC3-II band, normalized to the loading of each
lane (naphtol blue staining) and referred to “C” (untreated control) without BafA1, was shown. Western blots are the result of a significant experiment out of three
independent experiments. A histogram representing “% Basal Autophagic Flux (LC3-II T+BafA1/LC3-II T)” at 3 h (white bars) and 12 h (black bars) of treatment was
calculated as reported in the “MATERIAL and METHODS” section. The percentages represent the quotient between LC3-II band intensities in “T” and “T+ BafA1”.
“T” is treatment and “T+ BafA1” is treatment in the presence of BafA1. Naphthol blue (NB) stained membrane served as a loading control. The percentage of basal
autophagic flux is expressed as mean ± SEM of at least three independent experiments (n = 3). Student’s t-test *P < 0.05 and **P < 0.01.October 2020 | Volume 11 | Article 580343
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MA and Cpd18, which displayed values of autophagic flux of 49
and 54%, respectively (12 h, Figure 2B). Of note, CQ and BafA1,
two common drugs used to assess the autophagic flux (Klionsky
et al., 2016), triggered the greatest blockage of the autophagic flux
at both 3 h and 12 h (Figure 2B).
Cell viability, after 24 h of treatment, was explored through
the quantification of alamarBlue (AB) reduction. As shown in
Figure 3A, among the inhibitors used, 3-MA and CQ diminished
cell viability to 50% or below. Permeabilization of the external
membrane with propidium iodide (PI) was evaluated at 48 h of
treatment. The results evidenced that SBI (40%), 3-MA (70%),
BafA1 (96%), and CQ (80%) triggered the most significant levels
of cell lethality in growing medium, while cells challenged with
MHY, SAR, Cpd18, and SPT-1 preserved the integrity of their
plasma membrane (Figure 3B).
Altogether, despite some differences in their efficiency, MHY,
SBI, 3-MA, Cpd18, SAR405, Spautin-1, CQ, and BafA1 are bona
fide inhibitors of basal autophagy. Besides, our results prove that
the inhibition of basal autophagy is not deleterious for MEF
cultures in growing conditions.
Cytotoxic Autophagy Inhibitory Drugs
Trigger BAX- and/or BAK-Dependent Cell
Death and Caspase Activation
Apoptosis is the most frequent type of regulated cell death in
response to chemotherapeutical drugs. Apoptotic cell death was
reported in different cell models treated for more than 24 h with 3-
MA (Boya et al., 2005; Hou et al., 2012), or with BafA1 or CQ, used
as control compounds (Boya et al., 2003; Boya et al., 2005; Walls
et al., 2010; Wang et al., 2018). DNA staining of the treated cell
cultures with bis-benzimide was used to highlight the presence of
pyknotic and/or karyorrhectic nuclei, two of the most
characteristic morphological features of apoptosis. As shown inFrontiers in Pharmacology | www.frontiersin.org 7Figure 4A, MEFs cultured in the presence of SBI, 3-MA, CQ, or
BafA1 displayed pyknotic/karyorrhectic nuclear morphologies,
thus pointing to apoptosis as the leading subroutine of cell
death. Apoptosis is characterized by the sequential activation of
caspases, resulting in a well-organized disassembly of the cell.
Caspase activity was addressed at 24 and 48 h through the internal
cleavage of Ac-DEVD-afc, a widely-used fluorescent substrate of
caspases. Only the cell cultures subjected to SBI, 3-MA, CQ, or
BafA1 challenges displayed a significant increase of the caspase
activity with respect to the other inhibitors (Figure 4B). At 24 h, 3-
MA, CQ, and BafA1 were the top activators of caspases (Figure
4B), while SBI required 48 h of treatment to reach equivalent levels
of caspase activation. In line with these results, SBI, 3-MA, CQ, or
BafA1 or elicited the activation of the effector caspase-3 after 48 h
of treatment (Figure 4C). Adding the pan-inhibitor of caspases q-
VD-OPh to the culture media reverted the cleavage of caspase-3 in
response to the compounds mentioned before. Caspase-3 was
efficiently activated in response to these inhibitors, since we
observed the presence of a specific 120 kDa-cleaved fragment of
a-Fodrin, which was avoided with q-VD-OPh (Figure 4D). To
assess the involvement of caspases in the observed cellular toxicity,
we evaluated the cell death in the presence of q-VD-OPh (Figure
4E). To control these experiments, q-VD-OPh was used to block
cell death of cultures treated with staurosporine (STS), a canonical
trigger of apoptosis. In these conditions, we confirmed a decrease
of cell death from 77% (STS) to 15% (STS+q-VD-OPh, results not
shown). The addition of q-VD-OPh to the cultures attenuated the
cell death in response to all the autophagy inhibitory drugs tested
up to 48 h of treatment (Figure 4E and Supplementary Figures
2A, B). Finally, we explored the involvement of the mitochondrial
intrinsic pathway in the observed apoptotic cell death. As reported
before (Boya et al., 2005), Bax−/− Bak−/− (DKO) MEFs were
resistant against apoptotic cell death induced by CQ and BafA1.
Cell death of DKO MEFs and wt MEFs challenged with SBI, 3-A B
FIGURE 3 | Cells cultured in growing media undergo cell death in response to the autophagy inhibitory compounds, 3-methyladenine, SBI-0206965, Bafilomycin A1
or Chloroquine. MEFs were treated with the drugs at the concentrations stated in the panel. (A) After 24 h, cell viability was measured by the cellular ability to reduce
AB reagent. Bar value is the mean ± SEM (n = 3). Student’s t-test *P < 0.01, **P < 0.005 and ***P < 0.001. (B) After 48 h, the percentage of propidium iodide (PI)-
positive cells (dead cells) was determined by flow cytometry. Bar value is the mean ± SEM (n = 3). Student’s t-test **P < 0.005 and ***P < 0.001.October 2020 | Volume 11 | Article 580343
Chicote et al. 3-Methyladenine-Driven Cell Death and GenotoxicityMA, CQ, or BafA1 was compared. As shown in Figure 4F, DKO
MEFs were resistant against the cytotoxicity mediated by all the
employed compounds, including SBI and 3-MA. Altogether, these
results show that caspases and BAX and/or BAK orchestrate the
cell death induced by the assayed cytotoxic autophagy inhibitory
drugs. Therefore, cytotoxicity comes from a regulated intracellular
signaling rather than an uncontrolled mechanism of cell death.Frontiers in Pharmacology | www.frontiersin.org 8Among the Autophagy Inhibitors
Employed, 3-MA Is the Most Effective
Compound at Decreasing Cell Viability of
Several Ontologically Unrelated Human
Cell Lines
To confirm the cytotoxicity of the assayed autophagy inhibitory





FIGURE 4 | Cytotoxic inhibitors of autophagy engage the mitochondrial pathway of apoptotic cell death. MEFs were treated with the autophagy inhibitory drugs at
the concentrations stated in the panel. (A) After 24 h of 3-MA and BafA1 treatment or after 48 h of SBI and CQ treatment, cells were stained with bisbenzimide
33342 and analyzed by fluorescence microscopy. Arrowheads point to the typical images of apoptotic nuclei. Bar = 40 mm. Images representative of several
independent experiments are shown. (B) After 24 and 48 h of treatment, effector caspase activity (DEVDase activity) was quantified in arbitrary fluorescent units
(a.f.u.). Bar value is the mean ± SEM (n = 3). Student’s t-test **P < 0.005 and ***P < 0.001. Protein extracts of MEFs treated with 3-MA, BafA1, SBI, and CQ for 48 h
in the presence (+) or absence (−) of 40 mM of q-VD-OPh were analyzed by western blot. Intensity of the cleaved caspase-3 or 120 kDa a-Fodrin bands, normalized
to the loading of each lane, was shown. Naphthol blue (NB) stained membrane served as a loading control. The images represent one representative western out of
three independent experiments. The antibodies used were (C) anti-caspase-3 and (D) anti-a-Fodrin. (E) MEFs were challenged with the cytotoxic inhibitors of
autophagy for the time indicated in the panel in the presence (+QVD) or absence (–QVD) of the caspase inhibitor q-VD-OPh at 40 mM. Bar value is the mean ± SEM
(n = 3). Student’s t-test ***P < 0.001. (F) wt MEFs and Bax–/–Bak–/–MEFs (DKO MEFs) were challenged with the cytotoxic autophagy inhibitory drugs for 48 h. Drug
concentrations are displayed in the panel. Cell death was quantified by means of PI incorporation and flow cytometry. Data are expressed as mean ± SEM (n = 3).
Student’s t-test *P < 0.01, **P < 0.005 and ***P < 0.001.October 2020 | Volume 11 | Article 580343
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(human embryonic kidney), HeLa (cervix adenocarcinoma),
and SH-SY5Y (neuroblastoma), was challenged with the
initiation, nucleation, and completion inhibitors. As shown inFrontiers in Pharmacology | www.frontiersin.org 9Figure 5, 3-MA decreased the viability of all the assayed cell
lines to less than 40% compared to control populations. In the
same line, the 3-MA derivative Cpd18 also elicited a significant
reduction in cell viability in three out of four cell linesFIGURE 5 | Effects of autophagy inhibitory drugs on the cellular viability in different human cell lines. HCT116, HEK293, HeLa, and SH-SY5Y cells were treated with
the “Initiation” and “Nucleation” autophagy inhibitory drugs from previous experiments. Drug concentrations are indicated in the panel. Cell viability was measured by
the AB reducing procedure after 24 h of treatment. Bar value is the mean ± SEM (n = 3). Student’s t-test **P < 0.005 and ***P < 0.001.October 2020 | Volume 11 | Article 580343
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hand, the reduction of cell viability in response to SBI was
similar to the one observed with Cpd18 (Figure 5). Notably, at
the assayed concentrations, CQ and BafA1 were innocuous in
most of the cell lines. In sum, 3-MA emerges as the most
effective autophagy inhibitor at decreasing cell viability across
several unrelated cellular models.
Basal Autophagy-Deficient Cells Are More
Sensitive to 3-MA and SBI-Driven
Cytotoxicity
Deletion of the focal adhesion kinase family interacting protein
of 200 kDa (FIP200) avoids the formation of LC3-II, ATG16L1,
and PI3P-binding protein puncta (Itakura and Mizushima,
2010) and abrogates the emergence of the autophagy isolation
membrane (Kishi-Itakura et al., 2014; Tsuboyama et al., 2016).
Based on these characteristics and its apical position in the
autophagy pathway (Figure 1), it is considered as one of the
best genetic approaches to suppress basal and induced
autophagy. First, we assessed by western blot that Fip200−/−
MEFs presented reduced levels of basal and inducible
autophagy compared to their wild type genetic counterparts,
Fip200+/+ MEFs. As shown in Figure 6A, the generation of
LC3-II was markedly reduced in Fip200−/− MEFs maintained
in full media (“basal autophagy”, Figure 6A) or subjected to a
complete deprivation of nutrients and trophic factors
(“starvation” in Figure 6A). Likewise, p62 pool remained
elevated in both conditions (Figure 6A). These results
support that FIP200 is a key protein for both basal and
starvation-driven autophagy. To disprove that 3-MA- or SBI-
driven cytotoxicity was a consequence of the inhibition of basal
autophagy, we quantified the cell death induced by these
inhibitors in Fip200+/+ and Fip200−/− MEFs. As negative
controls, we included those non-cytotoxic compounds above-
employed (MHY, Cpd18, SAR and SPT-1), which remained
harmless after 48 h of incubation, regardless of the presence or
the absence of FIP200 (Figure 6B). In contrast, cell cytotoxicity
in response to 3-MA or SBI was enhanced in the autophagy-
suppressed background, Fip200−/− MEFs (Figure 6B). In
parallel, greater levels of caspase activity were observed in
Fip200−/− MEFs treated with 3-MA, SBI (Figure 6C) or with
the classical inducer of apoptosis, staurosporine (STS, Figure
6D). In sum, these results evidence that 3-MA- or SBI-mediated
cytotoxicities are not due to the inhibition of basal autophagy.
On the opposite, basal autophagy acts as a protective
mechanism facing 3-MA or SBI-mediated cell death.
3-MA-Driven Cytotoxicity Is Shared by Its
Structural Derivative Cpd18
We focused our interest on 3-MA-elicited cell death because of
its extensive use and its greater cytotoxicity compared to SBI (see
Figures 3, 5). 3-MA and Cpd18 are structurally related
compounds that differ in a methylpiperidin group positioned
at the C6 of the adenine (Figure 7A). We first confirmed the
ability of 10 mM 3-MA and 0.5 mM Cpd18 to inhibit the
autophagic flux. DALGreen is an innovative fluorescentFrontiers in Pharmacology | www.frontiersin.org 10molecule that stains the autophagosomes. Interestingly, the
fluorescence of DALGreen is enhanced at acidic pH, which is
suitable for monitoring the degradation phase of autophagy
(Iwashita et al., 2018). After 8 h, cells treated with 3-MA
(17.79 ± 0.96 a.u.f.) or Cpd18 (20.49 ± 0.94 a.u.f.) displayed a
diminished DALGreen fluorescent signal compared to control
populations (38.96 ± 1.08 a.u.f.), indicating that both compounds
inhibit the autophagic flux (Supplementary Figures 3A, B). 3-
MA is a widely-used drug to inhibit autophagy at concentrations
ranging from 2.5 to 10 mM, being 10 mM the most frequently
used (Seglen and Gordon, 1982; Petiot et al., 2000; Boya et al.,
2005; Devereaux et al., 2013). Nonetheless, the calculated IC80 of
3-MA and its close analog Cpd18 to suppress starvation-driven
autophagy are 6 and 1 mM, respectively (Wu et al., 2013). We re-
evaluated the autophagy inhibitory effects of 3-MA in a
concentration-dependent manner. In parallel, we also tested
Cpd18 at concentrations ranging from 0.25 to 2 mM. The
results with LC3-II and p62 evidenced a dose-dependent
reduction of the autophagic flux in response to 3-MA and
Cpd18 (Figure 7B and Supplementary Figure 3B, respectively).
Next, we evaluated the cell death using the afore-employed
concentrations of 3-MA and Cpd18. Cell death by 3-MA
remained lower than 25% at concentrations below 10 mM but
experienced an abrupt increase up to 82% at 10 mM (Figure 7C).
The same behavior was observed at 2 mM Cpd18, which triggered
a similar intensification of the cell cytotoxicity when increased
from 1 up to 2 mM (23 to 64%, respectively, Figure 7C). Notably,
the concentrations of 3-MA and Cpd18 that presented a greater
attenuation of the autophagic flux were the ones associated with
larger amounts of cell death. Altogether, these results stress the
relevance of 3-MA and Cpd18 backbone structure to block
autophagy as well as to engage cells into cell death.
Disruption of the AKT/mTOR Axis Is Not
the Main Mechanism Driving 3-MA-
Mediated Cell Death
In addition to its well-known inhibition of PI3K of class 3
(PI3KC3), 3-MA can also inhibit PI3K class 1 (PI3KC1) and
mTOR (Ito et al., 2007; Wu et al., 2010). This lack of selectivity
is also shared by wortmannin (Wn), an irreversible and
potent pan-inhibitor of PI3Ks, including VPS34 (a PI3KC3)
and mTOR (Arcaro and Wymann, 1993; Brunn et al., 1996).
First, we assessed the blockage of the autophagic flux by
wortmannin in a concentration-dependent manner. Among
the concentrations employed, 100 mM wortmannin was the
one exhibiting a most robust blockage of the autophagic flux
(Figure 8A) and, hence, this concentration was selected to
perform the following experiments. The serine/threonine
kinase AKT is a target of phosphoinositide-dependent protein
kinase-1 (PDK1), which is in turn regulated by PI3KC1 and
holds a pro-survival/anti-apoptotic role in response to growth
or survival factors. The activation of AKT is directed by two
phosphorylations: one in threonine 308 (Thr308) by PDK1 and
the other on serine 473 (Ser473) by several kinases, among
them, the complex 2 of mTOR (mTORC2). We confirmed by
Western blot that 10 mM 3-MA and 100 mM wortmannin wereOctober 2020 | Volume 11 | Article 580343
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already at 6 h of treatment (Figure 8B). Wortmannin triggered
a severe abrogation of Ser473 phosphorylation and a partial, but
intense, suppression of Thr308. Meanwhile, 3-MA was
diminishing the phosphorylation of both positions, with a
more pronounced inhibitory effect on Ser473. These results
indicate that wortmannin is more efficient than 3-MA in
inhibiting the activity of AKT, at least at the employed
concentrations. Our experiments included Cpd18 and
SAR405, which were reported to inhibit VPS34/PI3KC3
without affecting PI3KC1 (Wu et al., 2013; Ronan et al., 2014;
Pasquier, 2015). As shown in Figure 8B, we observed aFrontiers in Pharmacology | www.frontiersin.org 11reduction of both AKT phosphorylations in response to these
inhibitors. Nonetheless, the effects of SAR405 and Cpd18 were
less pronounced than the effects of 3-MA.
The phosphorylations of ULK (Ser757) and 4E-BP1 (Thr37/
46) are two surrogate markers of mTORC1 activity (Gingras
et al., 1999; Kim et al., 2011). Wortmannin efficiently prevented
the phosphorylation of ULK and 4E-BP1 at times as early as 6 h
of treatment (Figure 8B). However, we were unable to observe a
reduction of p-ULK in response to 3-MA. Likewise, 3-MA
triggered only a mild reduction of p-4E-BP1. Overall, these
results supported that differently from wortmannin, 3-MA was
a weak inhibitor of AKT and mTORC1 activity.A B
DC
FIGURE 6 | Fip200–/– MEFs display increased sensitivity to apoptosis triggered by 3-methyladenine or SBI-0206965, but not to MHY1485, Cpd18, SAR405 or
Spautin-1. (A) Protein extracts from Fip200–/– and Fip200+/+ MEFs cultured in full media or Hank’s buffer without glucose (starvation) for 6h, either in the presence
(+) or absence (–) of BafA1, were analyzed by western blot. Autophagy was evaluated by LC3-II and p62. Intensity of these bands, normalized to the loading of each
lane and referred to the values of these proteins in Fip200+/+ maintained in growing medium, was shown. Naphthol blue (NB) stained membrane served as a loading
control. The image belongs to a representative image out of three independent experiments. (B) Fip200–/– and Fip200+/+ MEFs were challenged with the drugs at
the concentrations indicated in the panel. After staining with PI, the percentage of dead cells was determined by flow cytometry. Bar value is the mean ± SEM (n =
3). Student’s t-test *P < 0.01 (C, D) Effector caspase activity (DEVDase activity) was quantified in arbitrary fluorescent units (a.f.u.) after 24 h of treatment with the
compounds indicated in the panel. Bar value is the mean ± SEM (n = 3). Student’s t-test *P < 0.01 and ***P < 0.001.October 2020 | Volume 11 | Article 580343
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as the main mechanisms of 3-MA-driven cytotoxicity, we
compared cell death in response to wortmannin or 3-MA.
Despite using high concentrations of wortmannin (100 mM),
cell death induced by 10 mM 3-MA was greater than the one in
response to wortmannin (15% cell death, Figure 8C). Moreover,
concentrations of wortmannin as high as 250 µM were still less
toxic (40% cell death by PI, Figure 8C) than 10 mM 3-MA (80%
cell death by PI, Figure 8C). In conclusion, while the inhibition
of PI3KC1 and/or mTOR can partially contribute to 3-MA-
mediated cell death, we rule out these phenomena as the main
mechanisms guiding the 3-MA-elicited apoptotic cell death.
3-MA Induces g-H2A.X in Cells at
Cytotoxic Concentrations
Next, we interrogated whether apoptotic concentrations of 3-MA
were also damaging the DNA. DNA damage was evaluated by
the presence of the phosphorylated histone H2A.X at Ser139,Frontiers in Pharmacology | www.frontiersin.org 12also known as g-H2A.X (Rogakou et al., 1998). First, we
evaluated the levels of g-H2A.X in response to growing
concentrations of 3-MA. As shown in Figure 9A, 10 mM of
3-MA promoted a prominent increase of g-H2A.X not paralleled
by non-cytotoxic concentrations of 3-MA (2.5 and 5 mM). These
results indicated a relationship between the degree of cytotoxicity
and the amounts of g-H2A.X. To further support this
observation, we explored the induction of g-H2A.X in Fip200
−/− MEFs, which were more sensitive to cytotoxicity driven by
10 mM 3-MA (Figure 6B). As depicted in Figure 9B, 3-MA-
treated Fip200−/− MEFs displayed greater amounts of g-H2A.X
as compared to Fip200+/+ MEFs. To test if the observed DNA
damage is a response restricted to 3-MA, we employed the
cytotoxic inhibitors studied before. As a control, we also
included SAR, a non-cytotoxic inhibitor of autophagy. As
shown in Figure 9C, increased levels of g-H2A.X were
evidenced in response to all of the cytotoxic inhibitors.
Remarkably, 3-MA stood as the top inducer of g-H2A.XA B
C
FIGURE 7 | Concentration-dependent cytotoxicity of 3-methyladenine and its structural derivative Cpd18. (A) Chemical structure of 3-MA and Cpd18 (images
borrowed from Selleckchem and MerckMillipore webpages, respectively). (B) Western blot of MEFs protein extracts treated for 8 h with growing concentrations of
3-MA and Cpd18 in the presence (+) or absence (–) of 100 nM BafA1 for the whole treatment. Intensity of the LC3-II band, normalized to the loading of each lane
(naphtol blue staining) and referred to “0” without BafA1, was shown. Western blots are a significant experiment out of three independent experiments. A histogram
representing “% Basal Autophagic Flux (LC3-II T+BafA1/LC3-II T)” was calculated as reported in the “MATERIAL and METHODS” section. The percentages represent
the quotient between LC3-II band intensities in “T” and “T+ BafA1”. “T” is treatment and “T+ BafA1”is treatment in the presence of BafA1. Naphthol blue (NB) stained
membrane served as a loading control. The percentage of basal autophagic flux is expressed as mean ± SEM of at least three independent experiments (n = 3).
(C) MEFs were treated with the concentrations of 3-MA and Cpd18 indicated in the panel. After 48 h, the percentage of propidium iodide (PI)-positive cells (dead
cells) was determined by flow cytometry. Bar value is the mean ± SEM (n = 3).October 2020 | Volume 11 | Article 580343
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was unable to promote g-H2A.X. These results discard, first, the
direct inhibition of VPS34 and second, the suppression of basal
autophagy, as the mechanisms accountable for the 3-MA-
mediated increase of H2A.X phosphorylation at Ser139. As far
as we know, this is the first time that the cytotoxic inhibitors of
autophagy, particularly 3-MA, emerge as inducers of DNA
damage, as detected by g-H2A.X.DISCUSSION
The pharmacological inhibition of autophagy, either alone or
in combination with other chemotherapeutical drugs, is under
investigation to become a fully accepted antitumoral strategy.Frontiers in Pharmacology | www.frontiersin.org 13In this sense, the therapeutic benefit of inhibiting the different
phases of the autophagic process remains a matter of debate
(Mulcahy Levy and Thorburn, 2020). Here, we employed
several classical or innovative pharmacological inhibitors of
autophagy, acting at the initiation, nucleation, or completion
phases of autophagy. We have interrogated the consequences
for cell viability when these inhibitors are incubated under
regular growing conditions. Despite some initial differences,
at 12 h most of the assayed compounds inhibit the autophagic
flux of MEF cells to a similar extent. Nonetheless, the
evaluation of cell death evidences the cytotoxic effects of
3-methyladenine, SBI-0206965, Bafi lomycin A1, and
Chloroquine and the non-cytotoxic profile of MHY1485,
Cpd18, SAR405, and Spautin-1. We examined the effects of
these compounds on the cell viability of tumor-derived cellA
B C
FIGURE 8 | AKT/PKB and/or mTORC1 inhibition are not the leading mechanisms of 3-methyladenine-mediated cytotoxicity. (A) Protein extracts of MEFs subjected
to growing concentrations of wortmannin either in the presence (+) or absence (–) of BafA1 for 8 h were analyzed by western blot. Autophagy was evaluated by LC3-
II. Naphthol blue (NB) stained membrane served as a loading control. The image belongs to a representative image out of two experiments. (B) Protein extracts of
control untreated MEFs (C) or MEFs treated with 10 mM 3-MA (3-MA), 100 mM Wortmannin (Wn), 5 mM SAR (SAR), 0.5 mM Cpd18 (Cpd18) at 6 and 12 h were
analyzed by western blot with antibodies against phospho-AKT (p-AKT) (Ser473 and 308), AKT1, p-ULK (Ser757), ULK, p-4E-BP1(Thr37/46), and 4E-BP1.
Quantifications are the ratios between the intensity of phosphorylated proteins normalized to unphosphorylated proteins. Naphthol blue (NB) stained membrane
served as a loading control. The images belong to a representative experiment out of three independent repetitions. (C) MEFs were treated for 48 h with the drugs at
concentrations stated in the panel. The percentage of propidium iodide (PI)-positive cells (dead cells) was determined by flow cytometry. Bar value is the mean ±
SEM (n = 3).October 2020 | Volume 11 | Article 580343
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embryonic cell line, HEK293. While most of the assayed
inhibitors are non-cytotoxic, 3-methyladenine triggers a
consistent and abrupt decrease of cell viability across all the
cell lines. These results are in agreement with Eng and
colleagues who have demonstrated that basal autophagy is
dispensable for the survival of several cell lines in growing
conditions. To impair autophagy, the authors employed
genetic strategies targeting ATG7, ULK, or VPS34, or
pharmacological approaches using the chloroquine analog,
Lys01 (Eng et al., 2016). Collectively, these data support that
the simple inhibition of basal autophagy is not cytotoxic for
normal or tumor-derived cells in growing conditions. One
possible explanation could be linked to the metabolic status of
the cell. Notably, cells in growing conditions have access to a
plethora of exogenous biomolecules necessary to fuel their
metabolism, thus potentially compensating the impairment of
the recycling pathways. In that sense, healthy metabolic cellsFrontiers in Pharmacology | www.frontiersin.org 14with impaired basal autophagy would undergo cell demise if, a
second, or even the same insult engages cytotoxic intracellular
pathways. In agreement with this idea, our results show that
some of the assayed autophagy inhibitors, for instance 3-
methyladenine , SBI-0206965 , Bafi lomycin A1 , and
Chloroquine, while blocking basal autophagy, they also
engage cell death. In this line, 3-methyladenine (Hou et al.,
2012), SBI-0206965 (Tang et al., 2017), chloroquine (Eng
et al., 2016), and Bafilomycin A1 (Yan et al., 2016) are
reported inducers of deleter ious cel lular outcomes
independently of their autophagy suppressive action. At the
concentrations employed in this study, these compounds
trigger cellular stresses that are able to initiate apoptotic
intracellular pathways. Despite the cell protection conferred
by q-VD-OPh, a subpopulation of cells still succumb to these
inhibitors, pointing to the involvement of other subroutines of
cell death. Notably, this situation is especially relevant in
chloroquine-treated cultures since q-VD-OPh rescues lessA B
C
FIGURE 9 | 3-methyladenine triggers the phosphorylation of H2A.X at Ser139. Western blots probed with antibodies against phosphorylated Ser139-H2A.X (g-
H2A.X) and total H2A.X are shown. Quantifications are the ratios between the intensity of g-H2A.X normalized to total H2A.X. Naphthol blue (NB) stained membrane
served as a loading control. (A) Protein extracts of wt MEFs treated with 3-MA at 2.5, 5, and 10 mM for 24 h. Extracts of control cells are depicted as “0”.
(B) Protein extracts of Fip200–/– and Fip200+/+ MEFs challenged during 24 h with 10 mM 3-MA or left untreated (C) Protein extracts of MEFs untreated (C) or
treated for 24 h with 5 mM SAR, for 20 and 40 h with 20 mM SBI and for 12 and 24 h with 10 mM 3-MA, 100 nM BafA1 and 50 mM CQ. Images in (A–C) are a
representative experiment out of, at least, three independent experiments.October 2020 | Volume 11 | Article 580343
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the mitochondrion, as revealed by the resilience of Bax−/−
Bak−/− double-knockout MEFs to undergo cell death. Our
studies place the mitochondrion as the central target of the
cytotoxic inhibitors of autophagy employed. According to
this, those inhibitors of autophagy that are unable to stress
the mitochondria would remain non-cytotoxic, regardless of
their capacity to impair basal autophagy. This idea is also
evidenced by employing Fip200−/− MEFs. Although these
cells present a dramatic reduction of basal autophagy, the
non-cytotoxic autophagy inhibitors remain non-cytotoxic,
probably as a consequence of their inability to alter the
mitochondrial homeostasis. On the opposite, autophagy
deficient Fip200−/− MEFs are more vulnerable to cell death
in response to compounds acting as disruptors of the
mitochondrial viability, for instance 3-methyladenine and
SBI-0206965. Basal or constitutive autophagy is active in
healthy cells cultured in growing conditions and contributes
to the preservation of cellular homeostasis. On the other hand,
inducible autophagy is a cellular stress-responsive adaptation
to unfavorable environmental conditions. In this sense,
chemo- and radiotherapy are stressful stimuli that elicit
inducible adaptative autophagy (Nagelkerke et al., 2015).
Our results support that starvation-induced autophagy is
not qualitatively superior than basal autophagy at protecting
cells from staurosporine-elicited cell death (results not
shown). In other words, inducible autophagy would be
insuffic ient to counterac t s taurospor ine-media ted
mitochondrial damage of cells under adverse metabolic
conditions (e.g., starved cells). The molecular clues that
differentiate basal and inducible autophagy, if any, are not
yet well characterized. Based on our own data and the more
recent literature, we surmise both types of autophagy are part
of the same continuum (“the basal-to-inducible autophagy
continuum”), only differentiated by their intensity.
3-methyladenine, the main subject of this study, is a
compound identical to the DNA adduct N3-methyl-adenine
(3meA). The DNA content of 3meA adducts increases in
response to metabolic intermediates (i.e., S-adenosyl-
methionine) or alkylating poisons (Rydberg and Lindahl,
1982). 3meA adduct, which projects into the minor groove of
the DNA, is a potent inhibitor of both RNA and most DNA
polymerases and accounts for most of the cytotoxicity in
response to alkylating drugs (Engelward et al., 1998; Johnson
et al., 2007). The collapse of unstable blocked replication forks
provokes double-stranded DNA breaks (DSBs) (Bobola et al.,
2012) and replication stress (Burhans and Weinberger, 2007).
The phosphorylation of histone H2A.X on Ser139 (g-H2A.X) is
a widely accepted marker of DSB (Rogakou et al., 1998). In our
experiments, cytotoxic concentrations of 3-methyladenine
trigger the most prominent induction of g-H2A.X compared
to the other cytotoxic inhibitors of autophagy. This
genotoxicity is not a direct consequence of caspase activation
since the addition of q-VD-OPh to the culture media is unable
to reduce the burst of 3-methyladenine-elicited g-H2A.X.
These results raise interesting questions about the mechanismFrontiers in Pharmacology | www.frontiersin.org 15of 3-methyladenine-mediated genotoxicity. It is tempting to
attribute this genotoxicity to the direct incorporation of 3-
methyladenine into the replicating DNA. However, 3-
methyladenine is an ambident nucleophile, and methylation
of DNA requires electrophilic compounds (Wu et al., 2013). In
this sense, in vitro experiments evidence the inefficiency of 3-
methyladenine at directly generating DNA breaks into plasmid
DNA (J. Ribas & V.J. Yuste, unshown data). One alternative
explanation could be related to the metabolic reprogramming
exerted by this drug. Strikingly, 3-methyladenine rewires the
carbohydrate metabolism resulting in an accumulation of
glucose-6-phosphate, fructose-6-phosphate and phosphoenol
pyruvate. This phenomenon is caused by cAMP and is
unrelated to its intrinsic autophagy inhibitory function (Caro
et al., 1988). In this sense, it is known that reducing sugars
(such as glucose-6-phosphate or fructose-6-phosphate) can
modify nucleic acids in a non-enzymatic reaction. Indeed,
glucose-6-phosphate and fructose-6-phosphate trigger DNA
damage, mutagenesis, and cytotoxicity (Bucala et al., 1985;
Levi and Werman, 2003). Based on our results and the
broad usage of 3-methyladenine, it would be of outstanding
interest to go deeply into the molecular mechanisms
of 3-methyladenine generating DNA damage and its
relationship with metabolic changes.
With regard to the protective role of FIP200-mediated
autophagy facing genotoxicity, we found that the upregulation
of g-H2A.X in response to 3-methyladenine is enhanced in the
autophagy-deficient Fip200−/− MEFs. However, the simple
inhibition of autophagy (either with SAR405 or in Fip200−/−
MEFs) is unable to increase g-H2A.X. These data indicate that
increased g-H2A.X is an autophagy-independent effect of 3-
methyladenine and that autophagy is counteracting this
genotoxic effects. This is in agreement with the role of
autophagy in regulating DNA repair (Hewitt and Korolchuk,
2017). Notably, FIP200 deficiency diminishes DNA repair in
response to irradiation, camptothecin or etoposide in a p62-
dependent manner, thus increasing the cytotoxicity mediated by
these stimuli (Bae and Guan, 2011). In support of these data, a
direct link between p62 and the DNA damage machinery was
established through the identification of its inhibitory role over
RNF168, an H2A ubiquitinase that is essential for the
recruitment of multiple DNA repair proteins (Wang et al.,
2016). Moreover, autophagy is increased in cells subjected to
an intense DNA damage in response to genotoxic stressors and is
necessary for the recovery from replication stress (Vanzo
et al., 2020).
Autophagy is known to counteract oncogenic transformation
of normal cells but, at the same time, it promotes tumor
progression and resistance of tumor-derived cells (Galluzzi
et al., 2017). For this reason, the inhibition of autophagy is
under consideration as a sensitizing mechanism towards
chemotherapeutic agents. Our results evidence that the
cytotoxic inhibitors of autophagy promote cytotoxicity and
increase DNA damage. The degree of genomic damage could
derive into diverse consequences: first, the engagement of
deleterious intracellular pathways if levels of DNA damageOctober 2020 | Volume 11 | Article 580343
Chicote et al. 3-Methyladenine-Driven Cell Death and Genotoxicitysurpass the cellular DNA repair capacity; or, second, the
survival of cells able to repair the inflicted DNA damage. In
this last scenario, tumor cells could accumulate genomic
mutations, thus potentially worsening their malignant
behavior. Among the cytotoxic inhibitors of autophagy
studied here, 3-methyladenine is the top inducer of DNA
damage. This compound shows unfavorable features to be
translated into the clinics since its poor hydrosolubility and
effective concentrations in the millimolar range (Seglen and
Gordon, 1982; Petiot et al., 2000; Boya et al., 2005; Wu et al.,
2010; Devereaux et al., 2013; Wu et al., 2013). However,
taking into consideration that autophagy also participates
in the evasion of tumor cells from immune surveillance,
the interest of targeting VPS34 in the field of cancer
immunotherapy is reinforced (Mgrditchian et al., 2017;
Noman et al., 2020). Indeed, the inhibition of VPS34 is
under consideration as an adjuvant therapy for the
inhibitors of the immune checkpoints (ICIs). SAR405, or the
new inhibitor of VPS34 SB02024, trigger an inflammatory
profile that allows the infiltration of antitumoral immune cells
to the tumor bed (Noman et al., 2020). Besides SAR405, our
research identifies MHY1485 and Spautin-1 as interesting
pharmacological tools in terms of their efficacy in blocking
autophagy and their lack of cytotoxicity. In this sense, our
studies support the interest of these drugs as safe and efficient
non-cytotoxic inhibitors of autophagy to potentially be
applied in new therapeutic strategies.
Overall, 3-methyladenine-driven DNA damage and
cytotoxicity call for acautionary usage of this drug in
those experimental paradigms where cell survival/death is
interrogated. On the other hand, the lack of cytotoxicity of
SAR405, MHY1485, and Spautin-1 portrays these compounds
as great tools to address the role of autophagy in cell survival/
death decisions, without the interference of distracting cytotoxic
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SUPPLEMENTARY FIGURE 1 | Quantification of monodansylcadaverine-
positive vesicles per cell. MEFs were treated for 6h with the autophagy inhibitory
drugs employed in this study. After staining with Monodansylcadaverine (MDC),
images from Figure 1 were analyzed using ImageJ software. Plots are the result of
counting MDC-positive vesicles of at least 50 cells per condition. Bar value is the
mean ± SEM. Student’s t-test **P<0.005 and ***P<0.001.
SUPPLEMENTARY FIGURE 2 | Cell death by 3-methyladenine, SBI-0206965,
Bafilomycin A1 and Chloroquine in the presence or absence of q-QVD-OPh. MEFs
were treated with the drugs at the concentrations stated in the figure. A) After 36h,
pictures using a phase contrast microscope were obtained. Scale bar: 50 mm. B)
After 24h and 48h, the percentage of propidium iodide (PI)-positive cells (dead cells)
was determined by flow cytometry. Bar value is the mean ± SEM (n=3). Student’s t-
test ***P<0.001.
SUPPLEMENTARY FIGURE 3 | 3-methyladenine or Cpd18 inhibit the
autophagic flux. A) Western blot of protein extracts from MEFs treated for 8h
with growing concentrations of 3-MA or Cpd18 in the presence (+) or absence
(-) of 100 nM BafA1. Intensity of the p62 band, normalized to the loading of
each lane (Naphtol Blue (NB) staining) and referred to “0” with BafA1, was
shown. The shown Western blot is a representative one out of 3 independent
experiments. MEFs were loaded with DALGreen reagent for 30 min before
subjecting them to fresh cell culture media (Control) or media containing 10 mM
3-MA, 0.5 mM Cpd18, 50 mM Chloroquine or 100 nM BafA1 for 8h. B)
Fluorescence images were obtained using an inverted microscope. Scale bar:
50 mm. Representative images are shown. C) Quantification of the “Averaged
DALGreen Intensity/cell” from at least 50 cells from three independent wells.
Fluorescence is expressed in “arbitrary units of fluorescence” (a.u.f.). Bar value
is the mean ± SEM. Student’s t-test ***P<0.001.
SUPPLEMENTARY FIGURE 4 | 3-methyladenine upregulates g-H2A.X
independently of the inhibition of caspase-3. Protein extracts of MEFs
untreated (Control) or 10 mM 3-MA treated for 24h in the presence or absence
of 40 mM of q-VD-OPh (QVD), were analyzed by western blot. The antibodies
used were anti-caspase-3, anti-g-H2A.X and anti-H2A.X. The membrane
stained with Naphtol Blue (NB) served as a loading control. The images are one
representative Western blot out of three independent experiments.October 2020 | Volume 11 | Article 580343
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